I am happy to announce that Dr. Luis Martinez has joined Stony Brook Medicine as an Associate Professor in the Department of Pathology and as a member of the Cancer Center.
Dr. Martinez completed his PhD from the University of Texas at Austin and his postdoctoral fellowship at UT MD Anderson Cancer Center. He has held faculty appointments at the University of Texas Medical Branch in Galveston and at the University of Mississippi Medical Center in Jackson. In addition, he served as a member of the Cancer Institute of the University of Mississippi Medical Center Cancer Institute. Dr. Martinez is PI of a new NCI R01 grant to support his research related to the transcriptional regulation of oncogenic properties of mutant p53. He has also received numerous other awards, including an NCI Mentored Career Development Award and Excellence in Research Awards (from the University of Mississippi), and he has authored 22 research manuscripts that have been published in leading journals, including his most recent senior author paper, entitled “Regulation of Nucleotide Metabolism by Mutant p53 Contributes to its Gain-of Function Activities” (Nature Communications, in press). In addition to his research activities, Dr. Martinez has served on many university committees, is an ad hoc reviewer for a number of first tier scientific journals, has served on national and international study sections, and he has been a course director in Biochemistry, Molecular Oncology, and Molecular Biology. While his primary focus will be on advancing his research related to the oncogenic gain of function of mutant p53 and other oncoproteins in solid tumors, Dr. Martinez will also participate in teaching graduate students, medical students, residents, and postdoctoral research fellows and he will also serve on various committees within the Department of Pathology, the Cancer Center and the School of Medicine.
Please join me in welcoming Dr. Martinez to Stony Brook Medicine.
R. Shroyer, MD, PhD
The Marvin Kuschner Professor and Chair of Pathology